This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Nov 21;347(21):1721-2; author reply 1721-2.

doi: 10.1056/NEJM200211213472119.

Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma

Andreas Geier, Carsten Gartung, Christoph G Dietrich

PMID: 12444194
DOI: 10.1056/NEJM200211213472119

Comment

Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma

Andreas Geier et al. N Engl J Med. 2002.

. 2002 Nov 21;347(21):1721-2; author reply 1721-2.

doi: 10.1056/NEJM200211213472119.

Authors

Andreas Geier, Carsten Gartung, Christoph G Dietrich

PMID: 12444194
DOI: 10.1056/NEJM200211213472119

No abstract available

PubMed Disclaimer

Comment on

Hepatitis B e antigen and the risk of hepatocellular carcinoma.
Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ; Taiwan Community-Based Cancer Screening Project Group. Yang HI, et al. N Engl J Med. 2002 Jul 18;347(3):168-74. doi: 10.1056/NEJMoa013215. N Engl J Med. 2002. PMID: 12124405
Hepatitis B e Antigen--the dangerous endgame of hepatitis B.
Liang TJ, Ghany M. Liang TJ, et al. N Engl J Med. 2002 Jul 18;347(3):208-10. doi: 10.1056/NEJMe020060. N Engl J Med. 2002. PMID: 12124411 No abstract available.

Similar articles

Hepatitis B e Antigen--the dangerous endgame of hepatitis B.
Liang TJ, Ghany M. Liang TJ, et al. N Engl J Med. 2002 Jul 18;347(3):208-10. doi: 10.1056/NEJMe020060. N Engl J Med. 2002. PMID: 12124411 No abstract available.
Hepatitis B e antigen and the risk of hepatocellular carcinoma.
Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ; Taiwan Community-Based Cancer Screening Project Group. Yang HI, et al. N Engl J Med. 2002 Jul 18;347(3):168-74. doi: 10.1056/NEJMoa013215. N Engl J Med. 2002. PMID: 12124405
Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, Chen CJ. Yang HI, et al. J Clin Oncol. 2010 May 10;28(14):2437-44. doi: 10.1200/JCO.2009.27.4456. Epub 2010 Apr 5. J Clin Oncol. 2010. PMID: 20368541
Hepatitis B virus infection--natural history and clinical consequences.
Ganem D, Prince AM. Ganem D, et al. N Engl J Med. 2004 Mar 11;350(11):1118-29. doi: 10.1056/NEJMra031087. N Engl J Med. 2004. PMID: 15014185 Review. No abstract available.
Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases.
Acalovschi M. Acalovschi M. Rom J Gastroenterol. 2003 Jun;12(2):123-30. Rom J Gastroenterol. 2003. PMID: 12853999 Review. No abstract available.

See all similar articles

Cited by

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC.
De Battista D, Zamboni F, Gerstein H, Sato S, Markowitz TE, Lack J, Engle RE, Farci P. De Battista D, et al. J Hepatocell Carcinoma. 2021 Nov 21;8:1399-1413. doi: 10.2147/JHC.S325959. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34849372 Free PMC article.
The different effects of adefovir dipivoxil and telbivudine on the prognosis of hepatitis b virus-related hepatocellular carcinoma patients after curative resection.
He L, Xia Z, Shen J, Zhang X, Peng W, Li C, Wen T. He L, et al. Medicine (Baltimore). 2019 Feb;98(6):e14386. doi: 10.1097/MD.0000000000014386. Medicine (Baltimore). 2019. PMID: 30732177 Free PMC article.
HBV reactivation and its management in HBV-related HCC patients undergoing HAIC-TKI-ICI therapy: A multicenter study.
Liu J, Sun B, Zou J, Zhang X, Li H, Hu H, Zhao H, Lu W, Ding X, Zhang G, Lei Z, Zheng C, Kan X. Liu J, et al. iScience. 2025 May 16;28(6):112689. doi: 10.1016/j.isci.2025.112689. eCollection 2025 Jun 20. iScience. 2025. PMID: 40510114 Free PMC article.
A preoperative nomogram predicts prognosis of patients with hepatocellular carcinoma after liver transplantation: a multicenter retrospective study.
Huang D, Shen Y, Zhang W, Guo C, Liang T, Bai X. Huang D, et al. BMC Cancer. 2021 Mar 16;21(1):280. doi: 10.1186/s12885-021-07938-x. BMC Cancer. 2021. PMID: 33726700 Free PMC article.
Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis.
Xu L, Dai F, Wang P, Li L, Zhang M, Xu M. Xu L, et al. BMC Surg. 2022 Sep 13;22(1):339. doi: 10.1186/s12893-022-01789-4. BMC Surg. 2022. PMID: 36100893 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information